Marc de Garidel

Marc de Garidel
Born1956 (age 69–70)
EducationÉcole Spéciale des Travaux Publics
Thunderbird School of Global Management
Harvard Business School
OccupationBusinessman
Known forFormer CEO, Ipsen (2010-16)
TitleCEO Abivax
Term2023-
Honours Legion Honneur Chevalier ribbon Knight Legion of Honour (2008)

Marc de Garidel is a French Biotech Entrepreneur. He is the CEO of Abivax, a French clinical-stage, publicly traded biotechnology company (ABVX at Euronext Paris and Nasdaq Global Market), which he joined in May 2023.

He is also the non-executive chairman of the pharmaceutical company Ipsen since 2010. He is on the board of Claris Bio, a Harvard Ophthalmology spin-off.